Featured Nobel Articles

Elizabeth Blackburn, a member of the Editorial Board of Aging, won the Nobel Prize in Physiology or Medicine 2009, while being a member of the board. Elizabeth Blackburn co-authored a paper published in the first (inaugural) issue of Aging.
Andrew V. Schally, Nobel Prize Laureate, published his paper in Aging.
Shinya Yamanaka won the Nobel Prize in Physiology and Medicine 2012. Shinya Yamanaka co-authored a paper published in Aging.

Learn about our FREE Post-Publication Promotion Services

Impact Journals to Present Scientific Integrity Process at 2022 SSP Annual Meeting

05-16-2022

BUFFALO, NY-May 16, 2022 – Impact Journals (based out of Buffalo, New York) is an international open-access publisher of journals in the field of biomedical sciences. Impact Journals is on a mission to provide scientists with the opportunity to share exceptional discoveries, offer services that enable rapid dissemination of results, and present vital findings from the many fields of biomedical science. This mission cannot be accomplished without following strong ethical standards.

Scientific integrity is a crucial component of scholarly publishing. At Impact Journals, a growing industry of digital technologies, tools, and ideas are constantly being added to a robust scientific integrity process. The Impact Journals Scientific Integrity Process is built around six main components:

Presence of ethics statements
Adherence to Industry Standards for Scientific Publishing
Rigorous and Insightful Peer Review
Elimination of Plagiarism
Image Forensics Service
If a problem arises post-publication, Impact Journals conducts investigations following COPE guidelines in cooperation with the authors and their affiliated institution.

During the 12:00pm Industry Breakout Session on June 1, Impact Journals will be presenting its full scientific integrity process at the 2022 Society for Scholarly Publishing (SSP) Annual Meeting at the Sheraton Grand Chicago Riverwalk in Chicago, Illinois.

More about Impact Journals:

Impact Journals is an open-access publisher, focusing on topics surrounding cancer research, all fields of aging research, and now, with a special focus on COVID-19 vulnerability as an age-dependent syndrome. Our goal is life without disease.

To learn more about Impact Journals, or any of our journals, please visit www.impactjournals.com.

Follow Impact Journals on social media:

Twitter – https://twitter.com/ImpactJrnls
Facebook – https://www.facebook.com/ImpactJrnls
LinkedIn – www.linkedin.com/company/impact-journals/

For media requests, please contact media@impactjournals.com.

###

**About Aging-US:**

Aging publishes research papers in all fields of aging research including but not limited, aging from yeast to mammals, cellular senescence, age-related diseases such as cancer and Alzheimer’s diseases and their prevention and treatment, anti-aging strategies and drug development and especially the role of signal transduction pathways such as mTOR in aging and potential approaches to modulate these signaling pathways to extend lifespan. The journal aims to promote treatment of age-related diseases by slowing down aging, validation of anti-aging drugs by treating age-related diseases, prevention of cancer by inhibiting aging. Cancer and COVID-19 are age-related diseases.

Aging is indexed by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed Central, Web of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Please visit our website at www.Aging-US.com and connect with us:

Facebook
X
Instagram
YouTube
LinkedIn
Reddit
Pinterest
Spotify, Apple, SoundCloud, and available wherever you listen to podcasts

For media inquiries, please contact media@impactjournals.com.